Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences (PLSE)
NASDAQ:PLSE
Holding PLSE?
Track your performance easily
Earnings Data
Report Date
Mar 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 30, 2018
|% Change Since: 11.40%
|Next Earnings Date:Jul 31, 2018
Earnings Call Sentiment|Positive
Pulse Biosciences showed strong clinical and regulatory progress, particularly with their innovative nano-PFA technology, while facing financial challenges due to increased losses and expenses. The company's financial position has strengthened significantly, providing a solid foundation for future developments.Company Guidance
During the Pulse Biosciences Q3 2024 earnings call, several key metrics and business updates were discussed. The company reported a GAAP net loss of $12.7 million for the quarter, an increase from $10.6 million in the prior year, with non-GAAP net loss at $9.4 million compared to $8.5 million. Total GAAP costs and expenses rose to $13.7 million, driven mainly by increased non-cash stock-based compensation expenses. The company successfully raised $60 million in gross proceeds through a rights offering, with potential for an additional $66 million from warrant exercises. Cash and cash equivalents totaled $79 million as of September 30, 2024, up from $44.4 million at the end of 2023. The call highlighted significant advancements in their nano-PFA technology, including FDA Breakthrough Device Designation for their cardiac surgery system, and the initiation of their first-in-human feasibility studies for new devices.First Patients Treated with AF Using Nano-PFA Cardiac Surgery System
Pulse Biosciences treated the first patients with atrial fibrillation (AF) using their nano-PFA cardiac surgery system in Europe, marking a significant milestone in their clinical applications.
FDA Breakthrough Device Designation
The cardiac surgery system received U.S. FDA Breakthrough Device Designation for the treatment of AF, and was enrolled in FDA's TAP program, providing even more accelerated pathways than Breakthrough.
Successful Rights Offering
The company completed their rights offering, raising $60 million in gross proceeds with the potential to raise an additional $66 million through the exercise of warrants.
Clinical Progress with Nano-PFA
Over 50 patients successfully treated with the 360 cardiac catheter, showing promise in efficiency and safety in atrial fibrillation treatments.
Financial Strengthening
As of September 30, 2024, cash and cash equivalents totaled $79 million, significantly up from $44.4 million as of December 31, 2023.
---
PLSE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PLSE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $17.72 | $17.43 | -1.64% |
| Aug 12, 2024 | $15.65 | $16.91 | +8.05% |
| May 07, 2024 | $7.60 | $6.90 | -9.21% |
| Mar 28, 2024 | $8.71 | $7.99 | -8.27% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Pulse Biosciences (PLSE) report earnings?
Pulse Biosciences (PLSE) is schdueled to report earning on Mar 27, 2025, TBA Not Confirmed.
What is Pulse Biosciences (PLSE) earnings time?
Pulse Biosciences (PLSE) earnings time is at Mar 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PLSE EPS forecast?
Currently, no data Available
---